Evidence map›Paper›PMID 28790436›Full record

ArticleScientific reports2017

Three TF Co-expression Modules Regulate Pressure-Overload Cardiac Hypertrophy in Male Mice.

Yao-Ming Chang, Li Ling, Ya-Ting Chang, Yu-Wang Chang, Wen-Hsiung Li, Arthur Chun-Chieh Shih, Chien-Chang Chen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in cardiovascular medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Yao-Ming ChangBiodiversity Research Center, Academia Sinica, Taipei, Taiwan.ORCID 0000-0002-6618-862X
Li LingInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Ya-Ting ChangInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Yu-Wang ChangInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Wen-Hsiung LiBiodiversity Research Center, Academia Sinica, Taipei, Taiwan.
Arthur Chun-Chieh ShihInstitute of Information Science, Academia Sinica, Taipei, Taiwan. arthur@iis.sinica.edu.tw.
Chien-Chang ChenInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. ccchen@ibms.sinica.edu.tw.
Institute of Biomedical Sciences, Academia Sinica · TWInstitute of Information Science, Academia Sinica · TWUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathological cardiac hypertrophy, a dynamic remodeling process, is a major risk factor for heart failure. Although a number of key regulators and related genes have been identified, how the transcription factors (TFs) dynamically regulate the associated genes and control the morphological and electrophysiological changes during the hypertrophic process are still largely unknown. In this study, we obtained the time-course transcriptomes at five time points in four weeks from male murine hearts subjected to transverse aorta banding surgery. From a series of computational analyses, we identified three major co-expression modules of TF genes that may regulate the gene expression changes during the development of cardiac hypertrophy in mice. After pressure overload, the TF genes in Module 1 were up-regulated before the occurrence of significant morphological changes and one week later were down-regulated gradually, while those in Modules 2 and 3 took over the regulation as the heart size increased. Our analyses revealed that the TF genes up-regulated at the early stages likely initiated the cascading regulation and most of the well-known cardiac miRNAs were up-regulated at later stages for suppression. In addition, the constructed time-dependent regulatory network reveals some TFs including Egr2 as new candidate key regulators of cardiovascular-associated (CV) genes.

Indexed as

AnimalsAortaCardiomegalyGene Expression ProfilingHypertensionLongitudinal StudiesMaleMiceRNA, MessengerTime FactorsTranscription FactorsRNA, MessengerTranscription Factors

Identifiers

PMID28790436
PMCPMC5548763
OpenAlexW2741431339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.